Tag: mid2025
Sensorion: 37 million in cash, visibility until mid-2025
(AOF) – Sensorion has net available cash of 37 million euros, and says it is capable of meeting its cash flow needs beyond the next twelve months, i.e. until the…
Tesla could produce its €25,000 electric car from mid-2025
Everything seems to be gradually falling into place around the launch of Tesla’s low-budget model for the second half of 2025. Model 2, A or any other name, nothing is…
Poxel: cash flow of 5.3 million euros, visibility until mid-2025 – 08/11/2023 at 6:25 p.m.
(AOF) – Poxel announces that as of September 30, 2023, its cash and cash equivalents amounted to 5.3 million euros. The biotech specialist in innovative treatments against metabolic diseases, including…
Poxel: cash flow of 5.3 million euros, visibility until mid-2025
(AOF) – Poxel announces that as of September 30, 2023, its cash and cash equivalents amounted to 5.3 million euros. The biotech specialist in innovative treatments against metabolic diseases, including…
Poxel: Funding secured through mid-2025
Read also (CercleFinance.com) – Poxel shares fell on the Paris Stock Exchange on Thursday, although analysts hailed the “comfortable” visibility of the biopharmaceutical company. At 2:30 p.m., the stock fell…
Poxel:7.6 million euros in cash, visibility until mid-2025 – 08/30/2023 at 6:03 p.m.
(AOF) – Poxel announces that as of June 30, 2023, its cash and cash equivalents amounted to 7.6 million euros compared to 13.1 million euros as of December 31, 2022.…
Poxel:7.6 million euros in cash, visibility until mid-2025
(AOF) – Poxel announces that as of June 30, 2023, its cash and cash equivalents amounted to 7.6 million euros compared to 13.1 million euros as of December 31, 2022.…
Innate Pharma: 135 million euros in cash, visibility until mid-2025 – 05/10/2023 at 09:59
(AOF) – Innate Pharma announces a cash position of 135.0 million euros as of March 31, 2023: the biotech specialist in cancer immunotherapy treatments says that its cash horizon runs…